StockTipsArenaBeta

BUY Aarti Pharmalabs Limited — Nilesh Jain, Centrum Broking

BUYAarti Pharmalabs Limited
Aarti Pharmalabs share price target & all analyst calls

byNilesh Jain, Centrum BrokingHorizon: NA (inferred Swing (≤2wk))10 Aug 2026via NDTV Profit (Live)

Entry₹823Inferred
Target₹850
Total upside +3.28% (call closed)
Stop loss₹800-2.79% risk
Exit₹85011 Aug 2026, 9:15 am
Target hit+3.28%0.00%upside left
Follow Nilesh Jain for new calls(32% target hit, 138 closed calls)Get alertsWatch AARTIPHARM for new buy/sell callsGet alertsSee 105 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 11 Aug 2026
1 supporting1 neutral0 opposing
Supports the BUY call (1)

Aarti Pharmalabs shares hit 20% upper circuit as Q1 net profit surges 65% YoY to Rs 76 crore

NewsEt-Markets·10 Aug · today

(opens in new tab)
Neutral / worth noting (1)

Aarti Pharmalabs Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·7 Aug · 3d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aarti Pharmalabs

All analyst calls on Aarti Pharmalabs

More from Nilesh Jain, Centrum Broking

Every call and its outcome